Skip to nav Skip to content
Facebook Twitter LinkedIn Email

IDSA Response to Full FDA Approval of the Pfizer-BioNTech COVID-19 Vaccine

“The FDA’s full approval of the Pfizer-BioNTech COVID-19 vaccine marks a pivotal milestone in the nation’s quest to control the effects of this pandemic. This approval is the culmination of intense, collaborative scientific research. 

The FDA’s announcement gives people who have not yet taken the vaccine additional assurance that this vaccine is safe and effective. 

Full FDA approval strengthens the case for vaccination requirements as an important strategy to curb infection and prevent hospitalizations and deaths due to COVID-19.

The most important takeaway from today’s announcement is to get vaccinated. The Pfizer-BioNTech COVID-19 vaccine has been proven to be safe and effective by the most rigorous, respected safety agency in the world.”

Barbara D. Alexander, MD, MHS, FIDSA – President Infectious Diseases Society of America

About IDSA
The Infectious Diseases Society of America (IDSA) is a community of over 12,000 physicians, scientists, and public health experts who specialize in infectious diseases. Its purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases. Learn more at

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.